2015;33:220.
33. Tay YK, Chan YC, Chandran NS, et al. Guidelines for the management of
atopic dermatitis in Singapore. Ann Acad Med Singap. 2016;45:439–450.
34. Republic of South Africa Essential Drugs Programme. Primary healthcare
standard treatment guidelines and essential medicines list. 5th ed. Republic
of South Africa: National Department of Health; 2014. http://www.kznhealth.
gov.za/pharmacy/edlphc2014a.pdf
35. Kim JE, Kim HJ, Lew BL, et al. Consensus guidelines for the treatment
of atopic dermatitis in Korea (part I): general management and topical
treatment. Ann Dermatol. 2015;27:563–577.
36. Kim JE, Kim HJ, Lew BL, et al. Consensus guidelines for the treatment
of atopic dermatitis in Korea (Part II): systemic treatment. Ann Dermatol.
2015;27:578–592.
37. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the
management of atopic dermatitis: section 2. Management and treatment of
atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71:116–
132.
38. van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM.
Emollients and moisturisers for eczema. Cochrane Database Syst Rev.
2017;2:CD012119. doi:10.1002/14651858.CD012119
39. Rerknimitr P, Otsuka A, Nakashima C, Kabashima K. Skin barrier function
and atopic dermatitis. Curr Dermatol Rep. 2018;7(4):209-220. doi:10.1007/
s13671-018-0232-y
40. Sahle FF, Gebre-Mariam T, Dobner B, Wohlrab J, Neubert RH. Skin diseases
associated with the depletion of stratum corneum lipids and stratum
corneum lipid substitution therapy. Skin Pharmacol Physiol. 2015;28:42–55.
41. Kim D, Lee NR, Park S-Y, et al. As in atopic dermatitis, non-lesional skin
in allergic contact dermatitis displays abnormalities in barrier function and
ceramide content. J Invest Dermatol. 2017;137(3):748-750. doi:10.1016/j.
jid.2016.10.034
42. Ito S, Ishikawa J, Naoe A, Yoshida H, et al. Ceramide synthase 4 is highly
expressed in involved skin of patients with atopic dermatitis. J Eur Acad
Dermatol Venereol. 2017;31:135–141.
43. Muizzuddin N, Hellemans L, Van Overloop L, Corstjens H, Declercq L,
Maes D. Structural and functional differences in barrier properties of
African American, Caucasian and East Asian skin. J Dermatol Science.
2010;59(2):123–128.
44. Strugar TL, Kuo A, et al. Connecting the dots: From skin barrier dysfunction
to allergic sensitization, and the role of moisturizers in repairing the skin
barrier. J Drugs Dermatol. 2019;18(6):581.
45. Del Rosso JQ, Harper J, Kircik L, et al. Consensus Recommendations on
Adjunctive Topical Management of Atopic Dermatitis. J Drugs Dermatol.
2018;17:1070-1076.
46. Lynde CW, Andriessen A. A cohort study on a ceramide-containing cleanser
and moisturizer used for atopic dermatitis. Cutis. 2014;93(4)207-2013.
47. Boralevi F, Saint Aroman M, Delarue A, Raudsepp H, Kaszuba A, Bylaite M,
et al. Long-term emollient therapy improves xerosis in children with atopic
dermatitis. J Eur Acad Dermatol Venereol. 2014;28:1456–1462.
48. Hirano SA, Murray SB, Harvey VM, et al. Reporting, representation, and
subgroup analysis of race and ethnicity in published clinical trials of atopic
dermatitis in the United States between 2000 and 2009. Pediatr Dermatol.
2012;29(6):749-55. doi: 10.1111/j.1525-1470.2012.01797.x.
49. Price KN, Krase JM, Loh TY et al. Racial and ethnic disparities in global atopic
dermatitis clinical trials. Br J Dermatol. 2020;183(2):378-380.
50. Callender VD, Alexis AF, Stein Gold LF et al. Efficacy and safety of crisaborole
ointment, 2%, for the treatment of mild-to-moderate atopic dermatitis
across racial and ethnic groups. Am J Clin Dermatol. 2019;20(5):711-723.
51. Alexis AF, Rendon M, Silverberg JI et al. Efficacy of dupilumab in different
racial subgroups of adults with moderate-to-severe atopic dermatitis in
three randomized, placebo-controlled phase 3 trials. J Drugs Dermatol.
2019;18(8):804-813.
52. Grayson MS, Heath CR. Dupilumab Improves Atopic Dermatitis and Post-
Inflammatory Hyperpigmentation in Patient With Skin of Color. J Drugs
Dermatol. 2020;19(7):776-778.
53. Tan HY, Zhang AL, Chen D, Xue CC, Lenon GB. Chinese herbal medicine for
atopic dermatitis: a systematic review. J Am Acad Dermatol. 2013,69:295-
304.
54. Whang KA, Khanna R, Thomas J, Aguh C, Kwatra SG. Racial and gender
differences in the presentation of pruritus. Medicines (Basel). 2019;6(4). doi:
10.3390/medicines6040098.
55. Liu P, Zhao Y, Mu ZL, et al. Clinical features of adult/adolescent atopic
dermatitis and Chinese criteria for atopic dermatitis. Chin Med J (Engl).
2016;129:757–762.
56. McColl M, Boozalis E, Aguh C, Eseonu AC, Okoye GA, Kwatra SG. Pruritus in
black skin: unique molecular characteristics and clinical features. J Nat Med
Assn. 2020. doi: 10.1016/j.jnma.2020.07.002. PubMed PMID: 32747312. 57. Shaw FM, Luk KMH, Chen KH, Wrenn G, Chen SC. Racial disparities in
the impact of chronic pruritus: A cross-sectional study on quality of life
and resource utilization in United States veterans. J Am Acad Dermatol.
2017;77(1):63-9. doi: 10.1016/j.jaad.2017.01.016.
58. Lynde CW, Tan J, Skotnicki S, Andriessen A. Clinical insights about the role
of skin pH in inflammatory dermatological conditions. J Drugs Dermatol.
2019;18(12)S-1:1-16.
59. Skotnicki S, Shulgan C. Beyond soap: The real truth about what you are doing
to your skin and how to fix it for a beautiful healthy glow: Penguin Canada.
2018.
60. Strugar TL, Kuo A, et al. Connecting the dots: From skin barrier dysfunction
to allergic sensitization, and the role of moisturizers in repairing the skin
barrier. J Drugs Dermatol. 2019;18(6):581.
61. Del Rosso JQ, Harper J, Kircik L, et al. Consensus Recommendations on
Adjunctive Topical Management of Atopic Dermatitis. J Drugs Dermatol.
2018;17:1070-1076.
62. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr
Metab. 2015;66 Suppl 1:8-16.
63. Leung DY. New insights into atopic dermatitis: role of skin barrier and
immune dysregulation. Allergology Internat. 2013;62(2):151-61. (Official
Journal of the Japanese Society of Allergology.)
64. Gittler JK, Shemer A, Suárez-Fariñas M, et al. Progressive activation of TH2/
TH22 cytokines and selective epidermal proteins characterizes acute and
chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130(6):1344-1354.
65. Draelos ZD, Baalbaki NH, Cook S, Raab S, Colon G. The effect of a ceramidecontaining
product on stratum corneum lipid levels in dry legs. J Drugs
Dermatol. 2020;19(4)372-376.
66. Luk D, Hon KLE, Dizon MVC, et al. Practical recommendations for the
topical treatment of atopic dermatitis in South and East Asia. Dermatol Ther
(Heidelb). 2021;11:275-291. https://doi.org/10.1007/s13555-020-00467-8
67. Zeichner JA, Del Rosso JQ. Multivesicular emulsion ceramide-containing
moisturizers: an evaluation of their role in the management of common skin
disorders. J Clin Aesthet Dermatol. 2016;9(12):26-32. PMID: 28210396 |
PMCID: PMC5300724
68. Lueangarun S, Tragulplaingam P, Sugkraroek S. The 24-hr, 28-day, and 7-day
post-moisturizing efficacy of ceramides 1, 3, 6-II containing moisturizing
cream on skin dryness and barrier disruption in senile xerosis treatment.
Dermatol Ther. 2019;32(6)e13090. https://doi.org/10.1111/dth.13090.
69. Danby SG, Andrew PV, Cork MJ et al. An investigation of the skin barrier
restoring effects of a cream containing ceramides in a multivesicular
emulsion in people with dry, eczema-prone, skin: The RESTORE study phase
I. Dermatol Ther (Heidelb). 2020; 10(5):1031-1041. https://doi.org/10.1007/
s13555-020-00426-3
70. Danby SG, Andrew PV, Cork MJ et al. An investigation of the skin barrier
restoring effects of a cream containing ceramides in a multivesicular
emulsion in people with dry, eczema-prone, skin: The RESTORE study phase
2. J Am Acad Dermatol. 2020;83(6) Suppl, AB71; Dec 1, 2020. DOI: https://
doi.org/10.1016/j.jaad.2020.06.373
71. Schachner LA, Andriessen A, Benjamin L, et al. A Consensus about the
Importance of ceramide containing skincare for normal and sensitive skin
conditions in neonates and infants. J Drugs Dermatol. 2020;19(8):769-776.
DOI: 10.36849/jdd.2020.5252 PMID: 32845590
72. Crudele J, Kim E, Murray K, Regan J. The importance of understanding
consumer preferences for dermatologist recommended skin cleansing and
care products. J Drugs Dermatol. 2019;18(1 Suppl):s75-79.
AUTHOR CORRESPONDENCE
Anneke Andriessen PhD anneke.a@tiscali.nl
